These tools revealed that spatial heterogeneity, rather than cell density, differentiates MGUS from newly diagnosed multiple myeloma (NDMM), highlighting the reduced proximity of BLIMP1+ tumor cells to CD8+ T cells in MGUS. This evidence concerns the gene PRDM1 and neoplasm.